J&J buys Intra-Cellular for US$ 14.6 bn; FTC exposes PBMs’ US$ 7.3 bn drug price markup scheme
The week saw the J.P. Morgan Healthcare Conference kick
off with a flurry of deals. In all, deals worth over US$ 19.3 billion ...
Impressions : 1724
Court dismisses Astra’s lawsuit over IRA price talks; Ozempic shows benefits to kidney, heart in diabetics with CKD
This week’s Phispers brings updates on the Inflation Regulation Act (IRA) in the US. A federal district court judge rejec...
Impressions : 1147
FDA safety review to hold up Moderna’s vaccine for teens; FDA raises concerns at Biocon’s Malaysia site
This
week, Phispers has more updates from Merck. The drugmaker has temporarily
withdrawn its pre-merger notification and repo...
Impressions : 1289
FDA proposes limits on ‘sartan’ nitrosamine impurities; Text messages add new twist to US generic price fixing litigation
In our final Phispers of 2018, we bring you news on how the big pharmaceutical companies in the US plan to ring in the new year...
Impressions : 5093
New Twists to Sartans Impurities Saga; Fish Oil Drug Makes Heart Medicine History
This week, Phispers brings you new twists to the valsartan impurities saga.
First, the FDA posted its observations at Zhejiang...
Impressions : 3650
Novartis seeks to clean image, links employee bonuses to ethics; EMA, FDA probe new impurity in valsartan
This week, Phispers brings you the latest on the valsartan contamination. FDA and EMA have found the presence of an additional ...
Impressions : 2764
- Privacy policy
- Terms and conditions
- Disclaimers
-
- Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.